
Use of physiologically based kinetic modeling-facilitated reverse dosimetry of in vitro toxicity data for prediction of in vivo developmental toxicity of tebuconazole in rats
Keywords: Physiologically based kinetic modeling; Reverse dosimetry; Developmental toxicity; Embryonic stem cell test; In vitro-in vivo extrapolation; Tebuconazole;